International Journal of Cardiology · 2013 · 100 citations · 32 references
MedicineOncologyPharmacologyCancer PharmacologyCardiovascular PharmacotherapyClinical PharmacologyAngiogenesisAtherosclerosis PharmacotherapyCardiovascular DiseaseCardiovascular Drug SafetyEndothelial DysfunctionAtherosclerotic ProgressionPlaque VulnerabilitySystemic Adverse EffectsVascular Endothelial Growth FactorVascular Endothelial Growth Factor InhibitionVascular Endothelial Growth Factor InhibitorsVascular Endothelial Growth Factor ReceptorsVascular Endothelial Growth Factor Signaling
32
Ranibizumab for Neovascular Age-Related Macular Degeneration
Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.9K citations · Full text
Medicine, Ophthalmology, Surgery +12
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text
Medicine, Oncology, Pharmacology +13